{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:38:04Z","timestamp":1790750284060,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T00:00:00Z","timestamp":1253059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-244x-9-57","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T18:14:03Z","timestamp":1253124843000},"source":"Crossref","is-referenced-by-count":37,"title":["Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects"],"prefix":"10.1186","volume":"9","author":[{"given":"Kwang H","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon W","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Weis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida C","family":"Llenos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette R","family":"Dulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H","family":"Yolken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maree J","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,16]]},"reference":[{"issue":"1-3","key":"605_CR1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.schres.2006.06.021","volume":"86","author":"AI Green","year":"2006","unstructured":"Green AI, Lieberman JA, Hamer RM, Glick ID, Gur RE, Kahn RS, McEvoy JP, Perkins DO, Rothschild AJ, Sharma T, et al: Olanzapine and haloperidol in first episode psychosis: two-year data. Schizophr Res. 2006, 86 (1-3): 234-243. 10.1016\/j.schres.2006.06.021.","journal-title":"Schizophr Res"},{"issue":"Suppl 1","key":"605_CR2","first-page":"S46","volume":"37","author":"S Bender","year":"2004","unstructured":"Bender S, Grohmann R, Engel RR, Degner D, Dittmann-Balcar A, Ruther E: Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics. Pharmacopsychiatry. 2004, 37 (Suppl 1): S46-53.","journal-title":"Pharmacopsychiatry"},{"issue":"6","key":"605_CR3","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.pnpbp.2006.03.014","volume":"30","author":"T Ozcanli","year":"2006","unstructured":"Ozcanli T, Erdogan A, Ozdemir S, Onen B, Ozmen M, Doksat K, Sonsuz A: Severe liver enzyme elevations after three years of olanzapine treatment: a case report and review of olanzapine associated hepatotoxicity. Prog Neuropsychopharmacol Biol Psychiatry. 2006, 30 (6): 1163-1166. 10.1016\/j.pnpbp.2006.03.014.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"605_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00004850-200505000-00009","volume":"20","author":"CU Pae","year":"2005","unstructured":"Pae CU, Lim HK, Kim TS, Kim JJ, Lee CU, Lee SJ, Lee C, Paik IH: Naturalistic observation on the hepatic enzyme changes in patients treated with either risperidone or olanzapine alone. Int Clin Psychopharmacol. 2005, 20 (3): 173-176. 10.1097\/00004850-200505000-00009.","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"605_CR5","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/00004714-200104000-00014","volume":"21","author":"I Gaertner","year":"2001","unstructured":"Gaertner I, Altendorf K, Batra A, Gaertner HJ: Relevance of liver enzyme elevations with four different neuroleptics: a retrospective review of 7,263 treatment courses. J Clin Psychopharmacol. 2001, 21 (2): 215-222. 10.1097\/00004714-200104000-00014.","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"605_CR6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","volume":"47","author":"P Seeman","year":"2002","unstructured":"Seeman P: Atypical antipsychotics: mechanism of action. Can J Psychiatry. 2002, 47 (1): 27-38.","journal-title":"Can J Psychiatry"},{"issue":"6","key":"605_CR7","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.pnpbp.2007.05.005","volume":"31","author":"N Atasoy","year":"2007","unstructured":"Atasoy N, Erdogan A, Yalug I, Ozturk U, Konuk N, Atik L, Ustundag Y: A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study. Prog Neuropsychopharmacol Biol Psychiatry. 2007, 31 (6): 1255-1260. 10.1016\/j.pnpbp.2007.05.005.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"605_CR8","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/00004714-199708000-00012","volume":"17","author":"M Hummer","year":"1997","unstructured":"Hummer M, Kurz M, Kurzthaler I, Oberbauer H, Miller C, Fleischhacker WW: Hepatotoxicity of clozapine. J Clin Psychopharmacol. 1997, 17 (4): 314-317. 10.1097\/00004714-199708000-00012.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"605_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/0278-5846(94)90010-8","volume":"18","author":"D Marinkovic","year":"1994","unstructured":"Marinkovic D, Timotijevic I, Babinski T, Totic S, Paunovic VR: The side-effects of clozapine: a four year follow-up study. Prog Neuropsychopharmacol Biol Psychiatry. 1994, 18 (3): 537-544. 10.1016\/0278-5846(94)90010-8.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"605_CR10","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1124\/jpet.107.124024","volume":"322","author":"WV Zhang","year":"2007","unstructured":"Zhang WV, Ramzan I, Murray M: Impaired microsomal oxidation of the atypical antipsychotic agent clozapine in hepatic steatosis. J Pharmacol Exp Ther. 2007, 322 (2): 770-777. 10.1124\/jpet.107.124024.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"605_CR11","first-page":"867","volume":"57","author":"A Haduch","year":"2005","unstructured":"Haduch A, Wojcikowski J, Daniel WA: Direct effects of neuroleptics on the activity of CYP2A in the liver of rats. Pharmacol Rep. 2005, 57 (6): 867-871.","journal-title":"Pharmacol Rep"},{"issue":"6","key":"605_CR12","first-page":"872","volume":"57","author":"A Haduch","year":"2005","unstructured":"Haduch A, Ogorka T, Boksa J, Daniel WA: Interactions between neuroleptics and CYP2C6 in rat liver--in vitro and ex vivo study. Pharmacol Rep. 2005, 57 (6): 872-877.","journal-title":"Pharmacol Rep"},{"issue":"6","key":"605_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1002\/jcla.10094","volume":"17","author":"MT Garcia-Unzueta","year":"2003","unstructured":"Garcia-Unzueta MT, Herran A, Sierra-Biddle D, Amado JA, Vazquez-Barquero JL, Alvarez C: Alterations of liver function test in patients treated with antipsychotics. J Clin Lab Anal. 2003, 17 (6): 216-218. 10.1002\/jcla.10094.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"605_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1021\/pr060308a","volume":"6","author":"S Prabakaran","year":"2007","unstructured":"Prabakaran S, Wengenroth M, Lockstone HE, Lilley K, Leweke FM, Bahn S: 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia. J Proteome Res. 2007, 6 (1): 141-149. 10.1021\/pr060308a.","journal-title":"J Proteome Res"},{"issue":"4","key":"605_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1017\/S1461145706007334","volume":"10","author":"D Tkachev","year":"2007","unstructured":"Tkachev D, Mimmack ML, Huffaker SJ, Ryan M, Bahn S: Further evidence for altered myelin biosynthesis and glutamatergic dysfunction in schizophrenia. Int J Neuropsychopharmacol. 2007, 10 (4): 557-563. 10.1017\/S1461145706007334.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"605_CR16","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1023\/B:NERE.0000023611.99452.47","volume":"29","author":"MP Vawter","year":"2004","unstructured":"Vawter MP, Shannon Weickert C, Ferran E, Matsumoto M, Overman K, Hyde TM, Weinberger DR, Bunney WE, Kleinman JE: Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia. Neurochem Res. 2004, 29 (6): 1245-1255. 10.1023\/B:NERE.0000023611.99452.47.","journal-title":"Neurochem Res"},{"issue":"7","key":"605_CR17","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1523\/JNEUROSCI.22-07-02718.2002","volume":"22","author":"FA Middleton","year":"2002","unstructured":"Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P: Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci. 2002, 22 (7): 2718-2729.","journal-title":"J Neurosci"},{"issue":"2","key":"605_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1385\/MN:34:2:109","volume":"34","author":"EA Thomas","year":"2006","unstructured":"Thomas EA: Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders. Mol Neurobiol. 2006, 34 (2): 109-128. 10.1385\/MN:34:2:109.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"605_CR19","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1007\/s00702-005-0425-y","volume":"113","author":"C Mehler-Wex","year":"2006","unstructured":"Mehler-Wex C, Grunblatt E, Zeiske S, Gille G, Rausch D, Warnke A, Gerlach M: Microarray analysis reveals distinct gene expression patterns in the mouse cortex following chronic neuroleptic and stimulant treatment: implications for body weight changes. J Neural Transm. 2006, 113 (10): 1383-1393. 10.1007\/s00702-005-0425-y.","journal-title":"J Neural Transm"},{"issue":"1-3","key":"605_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.schres.2006.03.029","volume":"85","author":"W Byne","year":"2006","unstructured":"Byne W, Kidkardnee S, Tatusov A, Yiannoulos G, Buchsbaum MS, Haroutunian V: Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus. Schizophr Res. 2006, 85 (1-3): 245-253. 10.1016\/j.schres.2006.03.029.","journal-title":"Schizophr Res"},{"issue":"5","key":"605_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/sj.tpj.6500323","volume":"5","author":"J Ferno","year":"2005","unstructured":"Ferno J, Raeder MB, Vik-Mo AO, Skrede S, Glambek M, Tronstad KJ, Breilid H, Lovlie R, Berge RK, Stansberg C, et al: Antipsychotic drugs activate SREBP-regulated expression of lipid biosynthetic genes in cultured human glioma cells: a novel mechanism of action?. Pharmacogenomics J. 2005, 5 (5): 298-304. 10.1038\/sj.tpj.6500323.","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"605_CR22","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.1371\/journal.pone.0000692","volume":"2","author":"RM Craddock","year":"2007","unstructured":"Craddock RM, Lockstone HE, Rider DA, Wayland MT, Harris LJ, McKenna PJ, Bahn S: Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms. PLoS ONE. 2007, 2 (1): e692-10.1371\/journal.pone.0000692.","journal-title":"PLoS ONE"},{"issue":"6 Pt 1","key":"605_CR23","first-page":"542","volume":"28","author":"G Dumortier","year":"2002","unstructured":"Dumortier G, Cabaret W, Stamatiadis L, Saba G, Benadhira R, Rocamora JF, Aubriot-Delmas B, Glikman J, Januel D: [Hepatic tolerance of atypical antipsychotic drugs]. Encephale. 2002, 28 (6 Pt 1): 542-551.","journal-title":"Encephale"},{"issue":"2","key":"605_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0920-9964(99)00192-9","volume":"44","author":"EF Torrey","year":"2000","unstructured":"Torrey EF, Webster M, Knable M, Johnston N, Yolken RH: The stanley foundation brain collection and neuropathology consortium. Schizophr Res. 2000, 44 (2): 151-155. 10.1016\/S0920-9964(99)00192-9.","journal-title":"Schizophr Res"},{"issue":"2","key":"605_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jneumeth.2007.06.001","volume":"165","author":"S Weis","year":"2007","unstructured":"Weis S, Llenos IC, Dulay JR, Elashoff M, Martinez-Murillo F, Miller CL: Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology. J Neurosci Methods. 2007, 165 (2): 198-209. 10.1016\/j.jneumeth.2007.06.001.","journal-title":"J Neurosci Methods"},{"key":"605_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2164-7-70","volume":"7","author":"BW Higgs","year":"2006","unstructured":"Higgs BW, Elashoff M, Richman S, Barci B: An online database for brain disease research. BMC Genomics. 2006, 7: 70-10.1186\/1471-2164-7-70.","journal-title":"BMC Genomics"},{"issue":"3","key":"605_CR27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1385\/JMN:31:03:221","volume":"31","author":"M Elashoff","year":"2007","unstructured":"Elashoff M, Higgs BW, Yolken RH, Knable MB, Weis S, Webster MJ, Barci BM, Torrey EF: Meta-analysis of 12 genomic studies in bipolar disorder. J Mol Neurosci. 2007, 31 (3): 221-243.","journal-title":"J Mol Neurosci"},{"key":"605_CR28","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1471-244X-8-87","volume":"8","author":"KH Choi","year":"2008","unstructured":"Choi KH, Elashoff M, Higgs BW, Song J, Kim S, Sabunciyan S, Diglisic S, Yolken RH, Knable MB, Torrey EF, et al: Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays. BMC Psychiatry. 2008, 8: 87-10.1186\/1471-244X-8-87.","journal-title":"BMC Psychiatry"},{"key":"605_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-60327-048-9_4","volume":"460","author":"M Elashoff","year":"2008","unstructured":"Elashoff M: Role of statistics in toxicogenomics. Methods Mol Biol. 2008, 460: 69-87.","journal-title":"Methods Mol Biol"},{"issue":"5","key":"605_CR30","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003, 4 (5): P3-10.1186\/gb-2003-4-5-p3.","journal-title":"Genome Biol"},{"issue":"9","key":"605_CR31","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/sj.npp.1301002","volume":"31","author":"SH Fatemi","year":"2006","unstructured":"Fatemi SH, Reutiman TJ, Folsom TD, Bell C, Nos L, Fried P, Pearce DA, Singh S, Siderovski DP, Willard FS, et al: Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique. Neuropsychopharmacology. 2006, 31 (9): 1888-1899. 10.1038\/sj.npp.1301002.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"605_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neuint.2005.04.020","volume":"47","author":"LZ Feher","year":"2005","unstructured":"Feher LZ, Kalman J, Puskas LG, Gyulveszi G, Kitajka K, Penke B, Palotas M, Samarova EI, Molnar J, Zvara A, et al: Impact of haloperidol and risperidone on gene expression profile in the rat cortex. Neurochem Int. 2005, 47 (4): 271-280. 10.1016\/j.neuint.2005.04.020.","journal-title":"Neurochem Int"},{"issue":"7","key":"605_CR33","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.biopsych.2006.12.021","volume":"62","author":"D Arion","year":"2007","unstructured":"Arion D, Unger T, Lewis DA, Levitt P, Mirnics K: Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry. 2007, 62 (7): 711-721. 10.1016\/j.biopsych.2006.12.021.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"605_CR34","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.mp.4001562","volume":"10","author":"KM Prasad","year":"2005","unstructured":"Prasad KM, Chowdari KV, Nimgaonkar VL, Talkowski ME, Lewis DA, Keshavan MS: Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients. Mol Psychiatry. 2005, 10 (2): 213-219. 10.1038\/sj.mp.4001562.","journal-title":"Mol Psychiatry"},{"key":"605_CR35","first-page":"675","volume-title":"AMA Archives of Neurology and Psychiatry","author":"V Kinross-Wright","year":"1956","unstructured":"Kinross-Wright V, Moyer JH: Chlorpromazine and Hepatic Function. AMA Archives of Neurology and Psychiatry. 1956, 675-680."},{"issue":"6","key":"605_CR36","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0016-5085(58)80083-9","volume":"34","author":"LG Bartholomew","year":"1958","unstructured":"Bartholomew LG, Cain JC, Frazier SH, Petersen MC, Foulk WT, Soule EH, Fleisher GA, Owen CA: Effect of chlorpromazine on the liver. Gastroenterology. 1958, 34 (6): 1096-1107.","journal-title":"Gastroenterology"},{"key":"605_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1744-9081-2-37","volume":"2","author":"M Shimabukuro","year":"2006","unstructured":"Shimabukuro M, Jinno Y, Fuke C, Okazaki Y: Haloperidol treatment induces tissue- and sex-specific changes in DNA methylation: a control study using rats. Behav Brain Funct. 2006, 2: 37-10.1186\/1744-9081-2-37.","journal-title":"Behav Brain Funct"},{"issue":"1-2","key":"605_CR38","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/BF02245620","volume":"124","author":"L Peacock","year":"1996","unstructured":"Peacock L, Solgaard T, Lublin H, Gerlach J: Clozapine versus typical antipsychotics. A retro- and prospective study of extrapyramidal side effects. Psychopharmacology (Berl). 1996, 124 (1-2): 188-196. 10.1007\/BF02245620.","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"605_CR39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF00287056","volume":"53","author":"S Madle","year":"1980","unstructured":"Madle S, Obe G, Schroeter H, Herha J, Pietzcker A: Possible mutagenicity of the psychoactive phenothiazine derivative perazine in vivo and in vitro. Hum Genet. 1980, 53 (3): 357-361. 10.1007\/BF00287056.","journal-title":"Hum Genet"},{"issue":"5","key":"605_CR40","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1742-7843.2007.00198.x","volume":"102","author":"Z Halici","year":"2008","unstructured":"Halici Z, Keles ON, Unal D, Albayrak M, Suleyman H, Cadirci E, Unal B, Kaplan S: Chronically Administered Risperidone Did Not Change the Number of Hepatocytes in Rats: A Stereological and Histopathological Study. Basic Clin Pharmacol Toxicol. 2008, 102 (5): 426-32. 10.1111\/j.1742-7843.2007.00198.x.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"605_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000100981","volume":"85","author":"G Tulipano","year":"2007","unstructured":"Tulipano G, Rizzetti C, Bianchi I, Fanzani A, Spano P, Cocchi D: Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation. Neuroendocrinology. 2007, 85 (2): 61-70. 10.1159\/000100981.","journal-title":"Neuroendocrinology"},{"issue":"5","key":"605_CR42","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jpsychires.2006.01.011","volume":"41","author":"A Pillai","year":"2007","unstructured":"Pillai A, Parikh V, Terry AV, Mahadik SP: Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatr Res. 2007, 41 (5): 372-386. 10.1016\/j.jpsychires.2006.01.011.","journal-title":"J Psychiatr Res"},{"issue":"Suppl 1","key":"605_CR43","first-page":"1","volume":"19","author":"JW Newcomer","year":"2005","unstructured":"Newcomer JW: Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs. 2005, 19 (Suppl 1): 1-93.","journal-title":"CNS Drugs"},{"issue":"Suppl 4","key":"605_CR44","first-page":"8","volume":"68","author":"JW Newcomer","year":"2007","unstructured":"Newcomer JW: Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry. 2007, 68 (Suppl 4): 8-13.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"605_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.legalmed.2007.12.006","volume":"10","author":"M Hanagama","year":"2008","unstructured":"Hanagama M, Inoue H, Kamiya M, Shinone K, Nata M: Gene expression on liver toxicity induced by administration of haloperidol in rats with severe fatty liver. Leg Med (Tokyo). 2008, 10 (4): 177-84.","journal-title":"Leg Med (Tokyo)"},{"issue":"3","key":"605_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0924-977X(03)00105-6","volume":"14","author":"J Wojcikowski","year":"2004","unstructured":"Wojcikowski J, Pichard-Garcia L, Maurel P, Daniel WA: The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes. Eur Neuropsychopharmacol. 2004, 14 (3): 199-208. 10.1016\/S0924-977X(03)00105-6.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"605_CR47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/dmd.105.006445","volume":"34","author":"J Wojcikowski","year":"2006","unstructured":"Wojcikowski J, Maurel P, Daniel WA: Characterization of human cytochrome p450 enzymes involved in the metabolism of the piperidine-type phenothiazine neuroleptic thioridazine. Drug Metab Dispos. 2006, 34 (3): 471-476.","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"605_CR48","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1046\/j.1471-4159.2002.01263.x","volume":"83","author":"D Ben-Shachar","year":"2002","unstructured":"Ben-Shachar D: Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine. J Neurochem. 2002, 83 (6): 1241-1251. 10.1046\/j.1471-4159.2002.01263.x.","journal-title":"J Neurochem"},{"issue":"2","key":"605_CR49","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1093\/hmg\/ddi022","volume":"14","author":"K Iwamoto","year":"2005","unstructured":"Iwamoto K, Bundo M, Kato T: Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet. 2005, 14 (2): 241-253. 10.1093\/hmg\/ddi022.","journal-title":"Hum Mol Genet"},{"issue":"11","key":"605_CR50","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/BF02980205","volume":"26","author":"JS Modica-Napolitano","year":"2003","unstructured":"Modica-Napolitano JS, Lagace CJ, Brennan WA, Aprille JR: Differential effects of typical and atypical neuroleptics on mitochondrial function in vitro. Arch Pharm Res. 2003, 26 (11): 951-959. 10.1007\/BF02980205.","journal-title":"Arch Pharm Res"},{"issue":"1","key":"605_CR51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/sj.bjp.0704672","volume":"136","author":"T Rodrigues","year":"2002","unstructured":"Rodrigues T, Santos AC, Pigoso AA, Mingatto FE, Uyemura SA, Curti C: Thioridazine interacts with the membrane of mitochondria acquiring antioxidant activity toward apoptosis--potentially implicated mechanisms. Br J Pharmacol. 2002, 136 (1): 136-142. 10.1038\/sj.bjp.0704672.","journal-title":"Br J Pharmacol"},{"issue":"1-3","key":"605_CR52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.schres.2008.03.004","volume":"103","author":"E Carrizo","year":"2008","unstructured":"Carrizo E, Fernandez V, Quintero J, Connell L, Rodriguez Z, Mosquera M, Acosta A, Baptista T: Coagulation and inflammation markers during atypical or typical antipsychotic treatment in schizophrenia patients and drug-free first-degree relatives. Schizophr Res. 2008, 103 (1-3): 83-93. 10.1016\/j.schres.2008.03.004.","journal-title":"Schizophr Res"},{"issue":"4","key":"605_CR53","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.biopsych.2003.09.007","volume":"55","author":"ML Mimmack","year":"2004","unstructured":"Mimmack ML, Brooking J, Bahn S: Quantitative polymerase chain reaction: validation of microarray results from postmortem brain studies. Biol Psychiatry. 2004, 55 (4): 337-345. 10.1016\/j.biopsych.2003.09.007.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"605_CR54","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2144\/04364ST03","volume":"36","author":"CL Miller","year":"2004","unstructured":"Miller CL, Diglisic S, Leister F, Webster M, Yolken RH: Evaluating RNA status for RT-PCR in extracts of postmortem human brain tissue. Biotechniques. 2004, 36 (4): 628-633.","journal-title":"Biotechniques"},{"issue":"26","key":"605_CR55","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1016\/j.lfs.2007.04.001","volume":"80","author":"S Park","year":"2007","unstructured":"Park S, Hong SM, Lee JE, Sung SR: Chlorpromazine exacerbates hepatic insulin sensitivity via attenuating insulin and leptin signaling pathway, while exercise partially reverses the adverse effects. Life Sci. 2007, 80 (26): 2428-2435. 10.1016\/j.lfs.2007.04.001.","journal-title":"Life Sci"},{"issue":"7","key":"605_CR56","doi-asserted-by":"publisher","first-page":"987","DOI":"10.2217\/14622416.7.7.987","volume":"7","author":"Q Xing","year":"2006","unstructured":"Xing Q, Gao R, Li H, Feng G, Xu M, Duan S, Meng J, Zhang A, Qin S, He L: Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients. Pharmacogenomics. 2006, 7 (7): 987-993. 10.2217\/14622416.7.7.987.","journal-title":"Pharmacogenomics"},{"issue":"2","key":"605_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/01.ypg.0000194441.04684.db","volume":"16","author":"T Takao","year":"2006","unstructured":"Takao T, Tachikawa H, Kawanishi Y, Katano T, Sen B, Homma M, Kohda Y, Mizukami K, Asada T: Association of treatment-resistant schizophrenia with the G2677A\/T and C3435T polymorphisms in the ATP-binding cassette subfamily B member 1 gene. Psychiatr Genet. 2006, 16 (2): 47-48. 10.1097\/01.ypg.0000194441.04684.db.","journal-title":"Psychiatr Genet"},{"issue":"2","key":"605_CR58","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0893-133X(02)00289-0","volume":"27","author":"O Kontkanen","year":"2002","unstructured":"Kontkanen O, Lakso M, Wong G, Castren E: Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex. Neuropsychopharmacology. 2002, 27 (2): 152-162. 10.1016\/S0893-133X(02)00289-0.","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"605_CR59","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1006\/exnr.2000.7612","volume":"168","author":"JJ Rodriguez","year":"2001","unstructured":"Rodriguez JJ, Garcia DR, Nakabeppu Y, Pickel VM: Enhancement of laminar FosB expression in frontal cortex of rats receiving long chronic clozapine administration. Exp Neurol. 2001, 168 (2): 392-401. 10.1006\/exnr.2000.7612.","journal-title":"Exp Neurol"},{"issue":"1-2","key":"605_CR60","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0169-328X(94)90207-0","volume":"23","author":"GA MacGibbon","year":"1994","unstructured":"MacGibbon GA, Lawlor PA, Bravo R, Dragunow M: Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Brain Res Mol Brain Res. 1994, 23 (1-2): 21-32. 10.1016\/0169-328X(94)90207-0.","journal-title":"Brain Res Mol Brain Res"},{"issue":"6","key":"605_CR61","first-page":"1085","volume":"34","author":"DS Abdalla","year":"1994","unstructured":"Abdalla DS, Bechara EJ: The effect of chlorpromazine and Li2CO3 on the superoxide dismutase and glutathione peroxidase activities of rat brain, liver and erythrocytes. Biochem Mol Biol Int. 1994, 34 (6): 1085-1090.","journal-title":"Biochem Mol Biol Int"},{"issue":"2","key":"605_CR62","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.biopsych.2007.11.010","volume":"64","author":"L Shao","year":"2008","unstructured":"Shao L, Vawter MP: Shared gene expression alterations in schizophrenia and bipolar disorder. Biol Psychiatry. 2008, 64 (2): 89-97. 10.1016\/j.biopsych.2007.11.010.","journal-title":"Biol Psychiatry"},{"key":"605_CR63","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1471-244X-7-46","volume":"7","author":"P Saetre","year":"2007","unstructured":"Saetre P, Emilsson L, Axelsson E, Kreuger J, Lindholm E, Jazin E: Inflammation-related genes up-regulated in schizophrenia brains. BMC Psychiatry. 2007, 7: 46-10.1186\/1471-244X-7-46.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"605_CR64","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00406-005-0603-9","volume":"256","author":"MJ Schwarz","year":"2006","unstructured":"Schwarz MJ, Kronig H, Riedel M, Dehning S, Douhet A, Spellmann I, Ackenheil M, Moller HJ, Muller N: IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2006, 256 (2): 72-76. 10.1007\/s00406-005-0603-9.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"4","key":"605_CR65","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/1073858406287536","volume":"12","author":"K Iwamoto","year":"2006","unstructured":"Iwamoto K, Kato T: Gene expression profiling in schizophrenia and related mental disorders. Neuroscientist. 2006, 12 (4): 349-361. 10.1177\/1073858406287536.","journal-title":"Neuroscientist"},{"issue":"5","key":"605_CR66","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/nbt965","volume":"22","author":"GL Miklos","year":"2004","unstructured":"Miklos GL, Maleszka R: Microarray reality checks in the context of a complex disease. Nat Biotechnol. 2004, 22 (5): 615-621. 10.1038\/nbt965.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"605_CR67","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.biopsych.2006.02.003","volume":"60","author":"K Mirnics","year":"2006","unstructured":"Mirnics K, Levitt P, Lewis DA: Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry. 2006, 60 (2): 163-176. 10.1016\/j.biopsych.2006.02.003.","journal-title":"Biol Psychiatry"},{"issue":"1-2","key":"605_CR68","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0891-0618(01)00099-0","volume":"22","author":"S Bahn","year":"2001","unstructured":"Bahn S, Augood SJ, Ryan M, Standaert DG, Starkey M, Emson PC: Gene expression profiling in the post-mortem human brain--no cause for dismay. J Chem Neuroanat. 2001, 22 (1-2): 79-94. 10.1016\/S0891-0618(01)00099-0.","journal-title":"J Chem Neuroanat"},{"issue":"4","key":"605_CR69","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.biopsych.2003.10.016","volume":"55","author":"MM Ryan","year":"2004","unstructured":"Ryan MM, Huffaker SJ, Webster MJ, Wayland M, Freeman T, Bahn S: Application and optimization of microarray technologies for human postmortem brain studies. Biol Psychiatry. 2004, 55 (4): 329-336. 10.1016\/j.biopsych.2003.10.016.","journal-title":"Biol Psychiatry"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-244X-9-57\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-9-57.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-9-57","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-244X-9-57.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T20:21:39Z","timestamp":1685132499000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/1471-244X-9-57"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,16]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["605"],"URL":"https:\/\/doi.org\/10.1186\/1471-244x-9-57","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,16]]},"article-number":"57"}}